Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.

被引：0
|
作者：
Xu, B.
Shen, L.
Ye, D.
Jappe, A.
Wang, H.
Yuan, R.
Wu, Y.
机构：
[1] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China
[2] Beijing Canc Hosp, Beijing, Peoples R China
[3] Fudan Univ, Canc Hosp, Shanghai 200433, Peoples R China
[4] Novartis Pharma AG, Basel, Switzerland
[5] Novartis Pharmaceut, Beijing, Peoples R China
[6] Novartis Pharmaceut, Florham Pk, NJ USA
[7] Univ Med & Dent New Jersey, Florham Pk, NJ USA
[8] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e13094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13094
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE I STUDY OF THE PHARMACOKINETICS AND TOLERABILITY OF EVEROLIMUS IN CHINESE PATIENTS WITH ADVANCED SOLID TUMORS
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Cherfi, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    ANNALS OF ONCOLOGY, 2010, 21 : 178 - 178
  • [2] Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.
    Rangwala, Fatima A.
    Bendell, Johanna C.
    Kozloff, Mark
    Arrowood, Christy
    Meadows, Jennifer
    Tourt-Uhlig, Sandra Ellen
    Murphy, Jennifer
    Meadows, Kellen
    Morse, Michael
    Uronis, Hope Elizabeth
    Hsu, Shiaowen David
    Zafar, Yousuf
    Hurwitz, Herbert
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors
    BingHe Xu
    YiLong Wu
    Lin Shen
    DingWei Ye
    Annette Jappe
    Azzeddine Cherfi
    Hui Wang
    RuiRong Yuan
    Journal of Hematology & Oncology, 4
  • [4] Two-dose-level confirmatory study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors
    Xu, BingHe
    Wu, YiLong
    Shen, Lin
    Ye, DingWei
    Jappe, Annette
    Cherfi, Azzeddine
    Wang, Hui
    Yuan, RuiRong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
  • [5] A Phase I Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Ipilimumab in Chinese Patients with Select Advanced Solid Tumors
    Ma, Yuxiang
    Fang, Wenfeng
    Zhao, Hongyun
    Bathena, Sai Praneeth
    Tendolkar, Amol
    Sheng, Jennifer
    Zhang, Li
    ONCOLOGIST, 2021, 26 (04): : E549 - E566
  • [6] Phase I study to assess the safety, tolerability, pharmacokinetics/pharmacodynamics and preliminary efficacy of SC10914 in patients with advanced solid tumors.
    Gong, Jifang
    Tang, Jinhai
    Yin, Yongmei
    Ye, Dingwei
    Zhang, Jian
    Zheng, Hong
    Gao, Yunong
    Jang, Haoyuan
    Chen, Xiao
    Zhang, Zhe
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Preliminary results of a phase I study of bevacizumab (BV) in combination with everolimus (E) in patients with advanced solid tumors.
    Zafar, Y.
    Bendell, J.
    Lager, J.
    Yu, D.
    George, D.
    Nixon, A.
    Petros, W.
    Beci, R.
    Arrowood, C.
    Hurwitz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 145S - 145S
  • [8] A phase I study of safety and pharmacokinetics of NanoBB-1-Dox in patients with advanced solid tumors.
    Filon, Olga
    Krivorotko, Petr
    Kobyakov, Grigory
    Razjivina, Viktoria
    Maximenko, Olga
    Gelperina, Svetlana
    Kreuter, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] A phase I QTc study of tivozanib in patients with advanced solid tumors.
    Chadha, Manpreet Kaur
    Infante, Jeffrey R.
    Cotreau, Monette M.
    Jacobson, Lindsey
    Strahs, Andrew Louis
    Slichenmyer, William
    Vargo, Dennis
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [10] Phase I study of sapacitabine and seliciclib in patients with advanced solid tumors.
    Tolaney, Sara M.
    Hilton, John Frederick
    Cleary, James M.
    Gandhi, Leena
    Kwak, Eunice Lee
    Clark, Jeffrey W.
    Wolanski, Andrew
    Bell, Tracy Demeo
    Rodig, Scott J.
    Chiao, Judy H.
    Blake, David
    Shapiro, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345